Cytotoxic (CD8+) T cells are part of a potent adaptive immune system to eliminate tumor cells by recognition of tumor peptides presented on major histocompatibility (MHC) class I molecules on tumor cells via their T cell receptors (TCRs). This evidence concerns the gene CD8A and neoplasm.